Metabolic dysfunction-associated steatotic liver disease : the tree that hides the forest? von Henin, G, Baldin, P, Frans, C, Havelange, V, Delire, B, Yombi, J C, Lanthier, N

Volltext

Hypogammaglobulinemia, a new risk factor for hepatitis B virus reactivation : about two cases von de Leuze, F, Havelange, V, van Dievoet, M-A, Horsmans, Y, Dahlqvist, G

Volltext

How skin and liver can lead to diagnosis von Vande Berg, P., Vande Berg, A., Harkemanne, E., Peeters, C., Havelange, V., Lanthier, N.

Volltext

Paraneoplastic retinopathy and optic neuropathy with Waldenström Macroglobulinemia von Ozturk, N., Havelange, V., Draganova, D., Boschi, A.

Volltext

MicroRNAs: new players in acute myeloid leukaemia von Havelange, V, Garzon, R, Croce, C M

Volltext

P406: ENHANCED SIGNIFICANCE OF FLT3‐ITD RESIDUAL DISEASE DETECTION ON TREATMENT OUTCOME IN ACUTE MYELOID LEUKEMIA von Grob, T., Sanders, M., Vonk, C., Kavelaars, F., Rijken, M., Hanekamp, D., Gradowska, P., Cloos, J., Fløisand, Y., Marwijk Kooy, M. V., Manz, M., Ossenkoppele, G., Tick, L., Havelange, V., Löwenberg, B., Jongen‐Lavrencic, M., Valk, P.

Volltext

P699: REAL‐LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) OR PHILADELPHIA CHROMOSOME‐POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL): 5‐YEAR‐DA... von Devos, T., Havelange, V., Theunissen, K., Meers, S., Benghiat, F. S., Gadisseur, A., Vanstraelen, G., Vellemans, H., Bailly, B., Granacher, N., Lewalle, P., De Becker, A., Van Eygen, K., Lejeune, M., Janssen, M., Triffet, A., Vrelust, I., Deeren, D., Mazure, D., Beck, M., Sebti, H., Selleslag, D.

Volltext

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia von DiNardo, Courtney D, Jonas, Brian A, Pullarkat, Vinod, Thirman, Michael J, Garcia, Jacqueline S, Wei, Andrew H, Konopleva, Marina, Döhner, Hartmut, Letai, Anthony, Fenaux, Pierre, Koller, Elizabeth, Havelange, Violaine, Leber, Brian, Esteve, Jordi, Wang, Jianxiang, Pejsa, Vlatko, Hájek, Roman, Porkka, Kimmo, Illés, Árpád, Lavie, David, Lemoli, Roberto M, Yamamoto, Kazuhito, Yoon, Sung-Soo, Jang, Jun-Ho, Yeh, Su-Peng, Turgut, Mehmet, Hong, Wan-Jen, Zhou, Ying, Potluri, Jalaja, Pratz, Keith W

Volltext

Molecular Minimal Residual Disease in Acute Myeloid Leukemia von Jongen-Lavrencic, Mojca, Grob, Tim, Hanekamp, Diana, Kavelaars, François G, al Hinai, Adil, Zeilemaker, Annelieke, Erpelinck-Verschueren, Claudia A.J, Gradowska, Patrycja L, Meijer, Rosa, Cloos, Jacqueline, Biemond, Bart J, Graux, Carlos, van Marwijk Kooy, Marinus, Manz, Markus G, Pabst, Thomas, Passweg, Jakob R, Havelange, Violaine, Ossenkoppele, Gert J, Sanders, Mathijs A, Schuurhuis, Gerrit J, Löwenberg, Bob, Valk, Peter J.M

Volltext

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine von Blum, William, Garzon, Ramiro, Klisovic, Rebecca B, Schwind, Sebastian, Walker, Alison, Geyer, Susan, Liu, Shujun, Havelange, Violaine, Becker, Heiko, Schaaf, Larry, Mickle, Jon, Devine, Hollie, Kefauver, Cheryl, Devine, Steven M, Chan, Kenneth K, Heerema, Nyla A, Bloomfield, Clara D, Grever, Michael R, Byrd, John C, Villalona-Calero, Miguel, Croce, Carlo M, Marcucci, Guido

Volltext

SUN-PO113: Investigation of the Gut Microbiota Composition and Activity in Acute Myeloid Leukemic Patients: First Clinical Results of the Microaml Study von Pötgens, S.A., Bindels, F., Havelange, V., Demoulin, J.-B., Moors, I., Kerre, T., Maertens, J., Schoemans, H., Delzenne, N., Bindels, L.

Volltext

Investigation Of The Gut Microbiota Composition And Activity In Acute Myeloid Leukemic Patients: First Results Of The Microaml Study von Pötgens, S.A., Bindels, F., Havelange, V., Li, F., Lecop, S., Neyrinck, A.M., Neveux, N., Demoulin, J.-B., Moors, I., Kerre, T., Maertens, J., Walter, J., Schoemans, H., Delzenne, N.M., Bindels, L.B.

Volltext

Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium von Devos, Timothy, Verhoef, Gregor, Steel, Eva, Mazure, Dominiek, Lewalle, Philippe, Bron, Dominique, Berneman, Zwi, Benghiat, Fleur Samantha, Mineur, Philippe, Theunissen, Koen, Zachée, Pierre, Doyen, Chantal, Put, Natalie, Lejeune, Marie, Van Eygen, Koen, Havelange, Violaine, Reusens, Michael, Pluymers, Wim, Peeters, Karen

Volltext

Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia von Havelange, Violaine, Demoulin, Jean-Baptiste

Volltext

PS1212 UPDATED RESULTS FROM PHASE I TRIALS ASSESSING A NKG2D CAR T‐CELL APPROACH IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME PATIENTS von Sallman, D.A., Davila, M., Brayer, J.B., Kerre, T., Poiré, X., Havelange, V., Lewalle, P., Al‐Homsi, S., Purev, E., Wang, E.S., Sotiropoulou, P.A., Braun, N., Lonez, C., Flament, A.

Volltext

PS937 RANDOMIZED PHASE III HOVON‐100 STUDY OF CLOFARABINE COMBINED WITH STANDARD TREATMENT IN ADULT PATIENTS WITH NEWLY DIAGNOSED ALL von Rijneveld, A., Holt, B., Weerdt, O., Biemond, B., Loosdrecht, A., Petersen, E., Bellido, M., Schouten, H., Velden, W., Selleslag, D., Schipperus, M., Halkes, S., Klein, S., Havelange, V., Marwijk Kooij, M., Legdeur, M.‐C., Deeren, D., Sinnige, H., Breems, D., Homburg, C., Haas, V., Velden, V., Cornelissen, J.

Volltext

Le traitement de la leucémie myéloïde aiguë: mise à jour von HAVELANGE, V, FERRANT, A

Volltext

Hypogammaglobulinemia, a new risk factor for hepatitis B virus reactivation : about two cases von de Leuze, F, Havelange, V, van Dievoet, M-A, Horsmans, Y, Dahlqvist, G

Volltext

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial von Rijneveld, A.W., Holt, B. van der, Weerdt, O. de, Biemond, B.J., Loosdrecht, A.A. van de, Wagen, L.E. van der, Bellido, M., Gelder, M. van, Velden, W.J.F.M. van der, Selleslag, D., Lammeren-Venema, D. van, Halkes, C.J.M., Fijnheer, R., Havelange, V., Sluis, G.L. van, Legdeur, M.C., Deeren, D., Gadisseur, A., Sinnige, H.A.M., Breems, D.A., Jaspers, A., Legrand, O., Terpstra, W.E., Boersma, R.S., Mazure, D., Triffet, A., Tick, L.W., Beel, K., Maertens, J.A., Beverloo, H.B., Bakkus, M., Homburg, C.H.E., Haas, V. de, Velden, V.H.J. van der, Cornelissen, J.J.

Volltext bestellen

Supplementary Material for: Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium von Devos, T., Verhoef, G., Steel, E., Mazure, D., Lewalle, P., Bron, D., Berneman, Z., Benghiat, F.S., Mineur, P., Theunissen, K., Zachée, P., Doyen, C., Put, N., Lejeune, M., VanEygen, K., Havelange, V., Reusens, M., Pluymers, W., Peeters, K.

Volltext bestellen